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Abstract
Studies of the human microbiome have revealed that even healthy individuals differ remarkably in 
the microbes that occupy habitats such as the gut, skin, and vagina. Much of this diversity remains 
unexplained, although diet, environment, host genetics, and early microbial exposure have all been 
implicated. Accordingly, to characterize the ecology of human-associated microbial communities, 
the Human Microbiome Project has analyzed the largest cohort and set of distinct, clinically 
relevant body habitats to date. We found the diversity and abundance of each habitat’s signature 
microbes to vary widely even among healthy subjects, with strong niche specialization both within 
and among individuals. The project encountered an estimated 81–99% of the genera, enzyme 
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families, and community configurations occupied by the healthy Western microbiome. 
Metagenomic carriage of metabolic pathways was stable among individuals despite variation in 
community structure, and ethnic/racial background proved to be one of the strongest associations 
of both pathways and microbes with clinical metadata. These results thus delineate the range of 
structural and functional configurations normal in the microbial communities of a healthy 
population, enabling future characterization of the epidemiology, ecology, and translational 
applications of the human microbiome.
A total of 4,788 specimens from 242 screened and phenotyped adults1–2 (129 males, 113 
females) were available for this study, representing the majority of the target HMP cohort of 
300 individuals. Adult subjects lacking evidence of disease were recruited based on a 
lengthy list of exclusion criteria; we will refer to them here as “healthy,” as defined by the 
consortium clinical sampling criteria2. Women were sampled at 18 body habitats, men at 15 
(excluding three vaginal sites), distributed among five major body areas. Nine specimens 
were collected from the oral cavity and oropharynx: saliva; buccal mucosa (cheek), 
keratinized gingiva (gums), palate, tonsils, throat, and tongue soft tissues; and supra- and 
subgingival dental plaque (tooth biofilm above and below the gum). Four skin specimens 
were collected from the two retroauricular creases (behind each ear) and the two antecubital 
fossae (inner elbows), and one specimen for the anterior nares (nostrils). A self-collected 
stool specimen represented the microbiota of the lower gastrointestinal tract, and three 
vaginal specimens were collected from the vaginal introitus, midpoint, and posterior fornix. 
In order to evaluate within-subject stability of the microbiome, 131 individuals in these data 
were sampled at an additional time point (mean 219 sd. 69 days after first sampling, range 
35–404 days). After quality control, these specimens were used for 16S rRNA gene analysis 
via 454 pyrosequencing (abbreviated henceforth as 16S profiling, mean 5,408 sd. 4,605 
filtered sequences/sample); to assess function, 681 samples were sequenced using paired-
end Illumina shotgun metagenomic reads (mean 2.9Gb sd. 2.1 per sample)1. More details on 
data generation are provided in related HMP publications1–2 and in Supplemental Methods.
Microbial diversity of healthy humans
The diversity of microbes within a given body habitat can be defined as the number and 
abundance distribution of distinct types of organisms, which has been linked to several 
human diseases: low diversity in the gut to obesity and inflammatory bowel disease3–4, for 
example, and high diversity in the vagina to bacterial vaginosis5. For this large study 
involving microbiome samples collected from healthy volunteers at two distinct geographic 
locations in the United States, we have defined the microbial communities at each body 
habitat, encountering 81–99% of predicted genera and saturating the range of overall 
community configurations (Fig. 1, Supp. Fig. 1, Supp. Table 1, see also Fig. 4). Oral and 
stool communities were especially diverse in terms of community membership, expanding 
prior observations6, and vaginal sites harbored particularly simple communities (Fig. 1A). 
This study established that these patterns of alpha diversity (within samples) differed 
markedly from comparisons between samples from the same habitat among subjects (beta 
diversity, Fig. 1B). For example, the saliva had among the highest median alpha diversities 
of Operational Taxonomic Units (OTUs, roughly species level classification, see http://
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hmpdacc.org/HMQCP), but one of the lowest beta diversities - so although each individual’s 
saliva was ecologically rich, members of the population shared similar organisms. 
Conversely, the antecubital fossae (skin) had the highest beta diversity but were intermediate 
in alpha diversity. The vagina had the lowest alpha diversity, with quite low beta diversity at 
the genus level but very high among OTUs due to the presence of distinct Lactobacillus spp. 
(Fig. 1B). The primary patterns of variation in community structure followed the major body 
habitat groups (oral, skin, gut, and vaginal), defining as a result the complete range of 
population-wide between-subject variation in human microbiome habitats (Fig. 1C). Within-
subject variation over time was consistently lower than between-subject variation, both in 
organismal composition and in metabolic function (Fig. 1D). The uniqueness of each 
individual’s microbial community thus appear to be stable over time (relative to the 
population as a whole), which may be another feature of the human microbiome specifically 
associated with health.
No taxa were observed to be universally present among all body habitats and individuals at 
the sequencing depth employed here, unlike several pathways (Fig. 2 and Supp. Fig. 2, see 
below), although several clades demonstrated broad prevalence and relatively abundant 
carriage patterns7–9. Instead, as suggested by individually focused studies3–4,6,10–11, each 
body habitat in almost every subject was characterized by one or a few signature taxa 
making up the plurality of the community (Fig. 3). Signature clades at the genus level 
formed on average anywhere from 17% to 84% of their respective body habitats, completely 
absent in some communities (0% at this level of detection) and representing the entire 
population (100%) in others. Strikingly, less dominant taxa were also highly personalized, 
both among individuals and body habitats; in the oral cavity, for example, most habitats are 
dominated by Streptococcus, but these are followed in abundance by Haemophilus in the 
buccal mucosa, Actinomyces in the supragingival plaque, and Prevotella in the immediately 
adjacent (but low oxygen) subgingival plaque12.
Additional taxonomic detail of the human microbiome was provided by identifying unique 
marker sequences in metagenomic data13 (Fig. 3A) to complement 16S profiling (Fig. 3B). 
These two profiles were typically in close agreement (Supp. Fig. 3), with the former in some 
cases offering more specific information on members of signature genera differentially 
present within habitats (e.g. vaginal Prevotella amnii and gut P. copri) or among individuals 
(e.g. vaginal Lactobacillus spp.) One application of this specificity was to confirm the 
absence of NIAID class A–C pathogens above 0.1% abundance (aside from S. aureus and E. 
coli) from the healthy microbiome, but the near-ubiquity and broad distribution of 
opportunistic “pathogens” as defined by PATRIC14. Canonical pathogens including Vibrio 
cholerae, Mycobacterium avium, Campylobacter jejuni, and Salmonella enterica were not 
detected at this level of sensitivity. Helicobacter pylori was found in only two gut samples, 
both at <0.01%, and E. coli was present at >0.1% abundance in 15% of stool microbiomes 
(>0% abundance in 61%). Similar species level observations were obtained for a small 
subset of stool samples with 454 pyrosequencing metagenomics data using PhylOTU15–16. 
In total 56 of 327 PATRIC “pathogens” were detected in the healthy microbiome (at >1% 
prevalence of >0.1% abundance, Supp. Table 2), all opportunistic and, strikingly, typically 
prevalent both among hosts and habitats. The latter is in contrast to many of the most 
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abundant signature taxa, which were usually more habitat-specific and variable among hosts 
(Fig. 3A–B). This overall absence of particularly detrimental microbes supports the 
hypothesis that even given this cohort’s high diversity, the microbiota tend to occupy a 
range of configurations in health distinct from many of the disease perturbations studied to 
date4,17.
Carriage of specific microbes
Inter-individual variation in the microbiome proved to be specific, functionally relevant, and 
personalized. One example of this is illustrated by the Streptococcus spp. of the oral cavity. 
The genus dominates the oropharynx18, with different species abundant within each sampled 
body habitat (see http://hmpdacc.org/HMSMCP) and, even at the species level, striking 
differences in carriage within each habitat among individuals (Fig. 4A). As the ratio of pan- 
to core-genomes is high in many human-associated microbes19, this variation in abundance 
could be due to selective pressures acting on pathways differentially present among 
Streptococcus species or strains (Fig. 4B). Indeed, we observed extensive strain-level 
genomic variation within microbial species in this population, enriched for host-specific 
structural variants around genomic islands (Fig. 4C). Even with respect to the single 
Streptococcus mitis strain B6, gene losses associated with these events were common, for 
example differentially eliminating S. mitis carriage of the V-type ATPase or choline binding 
proteins cbp6 and cbp12 among subsets of the host population (Fig. 4D). These losses were 
easily observable by comparison to reference isolate genomes, and these initial findings 
suggest that microbial strain- and host-specific gene gains and polymorphisms may be 
similarly ubiquitous.
Other examples of functionally relevant inter-individual variation at the species and strain 
levels occurred throughout the microbiome. In the gut, Bacteroides fragilis has been shown 
to prime T cell responses in animal models via the capsular polysaccharides PSA20, and in 
the HMP stool samples this taxon was carried at a level of at least 0.1% in 16% of samples 
(over 1% abundance in 3%). B. thetaiotaomicron has been studied for its effect on host 
gastrointestinal metabolism21 and was likewise common at 46% prevalence. On the skin, 
Staphylococcus aureus, of particular interest as the cause of methicillin-resistant S. aureus 
(MRSA) infections, had 29% nasal and 4% skin carriage rates, roughly as expected22. Close 
phylogenetic relatives such as S. epidermidis (itself considered commensal) were, in 
contrast, universal on the skin and present in 93% of nares samples, and at the opposite 
extreme Pseudomonas aeruginosa (a representative gram negative skin pathogen) was 
completely absent from both body habitats (0% at this level of detection). These and the data 
above suggest that the carriage pattern of some species in the human microbiome may be 
analogous to genetic traits, where recessive alleles of modest risk are maintained in a 
population. In the case of the human microbiome, high-risk pathogens remain absent, while 
species that pose a modest degree of risk also appear to be stably maintained in this 
ecological niche.
Finally, microorganisms within and among body habitats exhibited relationships suggestive 
of driving physical factors such as oxygen, moisture and pH, host immunological factors, 
and microbial interactions such as mutualism or competition23 (Supp. Fig. 4). Both overall 
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community similarity and microbial co-occurrence and co-exclusion across the human 
microbiome grouped the 18 body habitats together into four clusters corresponding to the 
five target body areas (Supp. Fig. 4A–B). There was little distinction among different 
vaginal sites, with Lactobacillus spp. dominating all three and correlating in abundance. 
However, Lactobacillus varied inversely with the Actinobacteria and Bacteroidetes (see 
Supp. Fig. 4C and Fig. 2–3), as also observed in the cohort of Ravel et al11. Gut microbiota 
relationships primarily comprised inverse associations with the Bacteroides, which ranged 
from dominant in some subjects to a minority in others who carried a greater diversity of 
Firmicutes. A similar progression was evident in the skin communities, dominated by one of 
Staphylococcus (phylum Firmicutes), Propionibacterium, or Corynebacterium (both phylum 
Actinobacteria), with a continuum of oral organisms (e.g. Streptococcus) appearing in nares 
communities (Supp. Fig. 4C). These observations suggest that microbial community 
structure in these individuals may sometimes occupy discrete configurations and under other 
circumstances vary continuously, a topic addressed in more detail by several HMP 
investigations7,24–25. An individual’s location within such configurations is indicative of 
current microbial carriage (including pathogens) and of the community’s ability to resist 
future pathogen acquisition or dysbiosis; it may thus prove to be associated with disease 
susceptibility or other phenotypic characteristics.
Microbiome metabolism and function
As the first study to include both marker gene and metagenomic data across body habitats 
from a large human population, we additionally assessed the ecology of microbial metabolic 
and functional pathways in these communities. We reconstructed the relative abundances of 
pathways in community metagenomes26, which were much more constant and evenly 
diverse than were organismal abundances (Fig. 2B, see also Fig. 1), confirming this as an 
ecological property of the entire human microbiome3. We were likewise able to determine 
for the first time that taxonomic and functional alpha diversity across microbial communities 
significantly correlate (Spearman of inverse Simpson’s r=0.60, p=3.6e-67, n=661), the latter 
within a more proscribed range of community configurations (Supp. Fig. 5).
Unlike microbial taxa, several pathways were ubiquitous among individuals and body 
habitats. The most abundant of these “core” pathways include the ribosome and translational 
machinery, nucleotide charging and ATP synthesis, and glycolysis, and reflect the basics of 
host-associated microbial life. Also in contrast to taxa, few pathways were highly variable 
among subjects within any body habitat; exceptions included the Sec (orally, sd. 0.0052, 
mean oral sd. 0.0011 sd. 0.0016) and Tat (globally, sd 0.0055, mean global sd. 0.0023 sd. 
0.0033) secretion systems, indicating a high degree of host-microbe and microbe-microbe 
interactions in the healthy human microbiota. This high variability was particularly present 
in the oral cavity, for phosphate, mono- and di-saccharide, and amino acid transport in the 
mucosa, as well as LPS biosynthesis and spermidine/putrescine synthesis and transport on 
the plaque and tongue (http://hmpdacc.org/HMMRC). The stability and high metagenomic 
abundance of this housekeeping “core” contrasts with the greater variability and lower 
abundance of niche-specific functionality in rare but consistently present pathways, e.g. 
spermidine biosynthesis, methionine degradation, and hydrogen sulfide production, all 
examples highly prevalent in gastrointestinal body sites (nonzero in >92% of samples) but at 
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very low abundance (median rel. abd. <0.0052). This “long tail” of low-abundance genes 
and pathways also likely encodes much of the uncharacterized biomolecular function and 
metabolism of these metagenomes, the expression levels of which remain to be explored in 
future metatranscriptomic studies.
Protein families showed diversity and prevalence trends similar to those of full pathways, 
ranging from maxima of only ~16,000 unique families per community in the vagina to 
almost 400,000 in the oral cavity (Fig. 1A–B, http://hmpdacc.org/HMGI). A striking 
fraction of these families were indeed functionally uncharacterized, including those detected 
by read mapping, with a minimum in the oral cavity (mean 58% sd. 6.8%) and maximum in 
the nares (mean 77% sd. 11%). Likewise, many genes annotated from assemblies could not 
be assigned a metabolic function, with a minimum in the vagina (mean 78% sd. 3.4%) and 
maximum in the gut (mean 86% sd. 0.9%). The latter range did not differ substantially by 
body habitat and is in close agreement with previous comprehensive gene catalogs of the gut 
metagenome4. Taken together with the microbial variation observed above throughout the 
human microbiome, functional variation among individuals might indicate pathways of 
particular importance in maintaining community structure in the face of personalized 
immune, environmental, or dietary exposures among these subjects. Determining the 
functions of uncharacterized core and variable protein families will be especially essential in 
understanding the microbiota’s role in health and disease.
Correlations with host phenotype
We finally examined relationships associating both clades and metabolism in the microbiota 
with host properties such as age, gender, BMI, and other available clinical metadata (Fig. 5; 
Supp. Table 3). Using a sparse multivariate model, 960 microbial, enzymatic, or pathway 
abundances were significantly associated with one or more of 15 subject phenotype and 
sample metadata features. A wide variety of taxa, gene families, and metabolic pathways 
were differentially distributed with subject ethnicity at every body habitat (Fig. 5A), 
representing the phenotype with the greatest number 266 at FDR q<0.2) of total associations 
with the microbiome. Vaginal pH has also been observed to correlate with microbiome 
composition11, and we detected in this population both the expected reduction in 
Lactobacillus at high pH and a corresponding increase in metabolic diversity (Fig. 5B). 
Intriguingly, and not previously observed, subject age was most associated with a collection 
of highly differential metagenomically encoded pathways on the skin (Fig. 5C), as well as 
shifts in skin clades including retroauricular Firmicutes (p=1.0e-4, q=0.033). The examples 
of associations with ethnicity and vaginal pH are among the strongest associations with the 
microbiome, however, and most correlates (e.g. with subject BMI, Fig. 5D) are more 
representatively modest. This lower degree of correlation held for most available biometrics 
(gender, temperature, blood pressure, etc.), with even the most significant associations 
possessing generally low effect sizes and considerable unexplained variance. We conclude 
that most variation in the human microbiome is not well-explained by these phenotypic 
metadata, and other potentially important factors such as short- and long-term diet, daily 
cycles, founder effects such as mode of delivery, and host genetics should be considered in 
future analyses.
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Conclusions
This extensive sampling of the human microbiome across many subjects and body habitats 
provides an initial characterization of the normal microbiota of healthy adults in a Western 
population. The large sample size and consistent sampling of many sites from the same 
individuals allows for the first time an understanding of the relationships among microbes, 
and between the microbiome and clinical parameters, that underpin the basis for individual 
variation -- variation that may ultimately be critical for understanding microbiome-based 
disorders. Clinical studies of the microbiome will be able to leverage the resulting extensive 
catalogs of taxa, pathways, and genes1, although they must also still include carefully 
matched internal controls. The uniqueness of each individual’s microbiome even in this 
reference population argues for future studies to consider prospective within-subjects 
designs where possible. The HMP’s unique combination of organismal and functional data 
across body habitats, encompassing both 16S and metagenomic profiling, together with 
detailed characterization of each subject, has allowed us and subsequent studies to move 
beyond the observation of variability in the human microbiome to ask how and why these 
microbial communities vary so extensively.
Many details remain for further work to fill in, building on this reference study. How do 
early colonization and life-long change vary among body habitats? Do epidemiological 
patterns of transmission of beneficial or harmless microbes mirror patterns of transmission 
of pathogens? Which co-occurrences among microbes reflect shared response to the 
environment, as opposed to competitive or mutualistic interactions? How large a role does 
host immunity or genetics play in shaping patterns of diversity, and how do the patterns 
observed in this North American population compare to those around the world? Future 
studies building on the gene and organism catalogs established by the Human Microbiome 
Project, including increasingly detailed investigations of metatranscriptomes and 
metaproteomes, will help to unravel these open questions and allow us to more fully 
understand the links between the human microbiome, health, and disease.
Methods Summary
Microbiome samples were collected from up to 18 body sites at one or two time points from 
242 individuals clinically screened for absence of disease2. Samples were subjected to 16S 
rRNA gene pyrosequencing (454 Life Sciences), and a subset were shotgun sequenced for 
metagenomics using the Illumina GAIIx platform1. 16S data processing and diversity 
estimates were performed using QIIME27, and metagenomic data were taxonomically 
profiled using MetaPhlAn13, metabolically profiled by HUMAnN26, and assembled for gene 
annotation and clustering into a unique catalog1. Potential pathogens were identified using 
the PATRIC database14, isolate reference genome annotations drawn from KEGG28, and 
reference genome mapping performed by BWA29 to a reduced set of genomes to which 
short reads could be matched30. Microbial associations were assessed by similarity measures 
accounting for compositionality23, and phenotypic association testing was performed in R. 
All data and additional protocol details are available at http://hmpdacc.org. Full methods 
accompany this paper.
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Figure 1. Diversity of the human microbiome is concordant among measures, unique to each 
individual, and strongly determined by microbial habitat
A) Alpha diversity within subjects by body habitat, as measured using the relative inverse 
Simpson index of 16S rRNA gene OTUs (red), genus-level phylotypes (blue), shotgun 
metagenomic reads matched to reference genomes (green), functional modules (yellow), and 
enzyme families (white). The mouth generally shows high within-subject diversity and the 
vagina low diversity, with other habitats intermediate; variation among individuals often 
exceeds variation among body habitats. B) Bray-Curtis beta diversity among subjects by 
body habitat, colors as for A. Skin differs most between subjects, with oral habitats and 
vaginal genera more stable. Although alpha- and beta-diversity are not directly comparable, 
changes in structure among communities (A) occupy a wider dynamic range than do 
changes within communities among individuals (B). C) Principal coordinates plot showing 
variation among samples demonstrates that primary clustering is by body area, with the oral, 
gastrointestinal, skin, and urogenital habitats separate; the nares bridge oral and skin 
habitats. D) Repeated samples from the same subject (red) are more similar than 
microbiomes from different subjects (yellow). Technical replicates (green) are in turn more 
similar; these patterns are consistent for all body habitats and for both phylogenetic and 
metabolic community composition. See previously described sample counts1 for all 
comparisons.
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Figure 2. Carriage of microbial taxa varies while metabolic pathways remain stable within a 
healthy population
Vertical bars represent microbiome samples by body habitat in the seven locations with both 
shotgun and 16S data; bars indicate relative abundances colored by A) microbial phyla from 
binned OTUs and B) metabolic modules. Legend indicates most abundant phyla/pathways 
by average within one or more body habitats; RC = retroauricular crease. A plurality of most 
communities’ memberships consists of a single dominant phylum (and often genus; see 
Supp. Fig. 2), but this is universal neither to all body habitats nor to all individuals. 
Conversely, most metabolic pathways are evenly distributed and prevalent across both 
individuals and body habitats.
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Figure 3. Abundant taxa in the human microbiome, which has been metagenomically and 
taxonomically well-defined in the HMP population
A–C) Prevalence (intensity, color denoting phylum/class) and abundance when present 
(size) of clades in the healthy microbiome. The most abundant A) metagenomically-
identified species, B) 16S-identified genera, and C) PATRIC14 “pathogens” (metagenomic). 
The population size and sequencing depths of the HMP have well-defined the microbiome at 
all assayed body sites, as assessed by saturation of added community D) metabolic 
configurations (rarefaction of minimum Bray-Curtis β-diversity of metagenomic EC 
abundances to nearest neighbor, inter-quartile range over 100 samples) and E) phylogenetic 
configurations (min. 16S OTU weighted UniFrac distance to nearest neighbor).
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Figure 4. Microbial carriage varies between subjects down to the species and strain level
Metagenomic reads from 127 tongue samples spanning 90 subjects were processed with 
MetaPhlAn to determine relative abundances for each species. A) Relative abundances of 11 
distinct Streptococcus spp. In addition to variation in broader clades (see Fig. 2), individual 
species within a single habitat demonstrate a wide range of compositional variation. Inset 
illustrates average tongue sample composition. B) Metabolic modules present/absent (grey/
white) in KEGG28 reference genomes of tongue streptococci denote selected areas of strain-
specific functional differentiation. C) Comparative genomic coverage for the single 
Streptococcus mitis B6 strain. Grey dots are median Reads Per Kilobase per Million reads 
(RPKM) for 1kb windows, gray bars are the 25th to 75th percentiles across all samples, red 
line the lowess smoothed average. Red bars at the bottom highlight predicted genomic 
islands31. Large, discrete, and highly variable islands are commonly under-represented. D) 
Two islands highlighted, V = V-type H+ ATPase subunits I,K,E,C,F,A & B, and CH = 
Choline binding proteins cbp6 and cbp12, indicating functional cohesion of strain-specific 
gene loss within individual human hosts.
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Figure 5. Microbial community membership and function correlates with host phenotype and 
sample metadata
The pathway and clade abundances most significantly associated (all FDR q<0.2) using a 
multivariate linear model with A) subject race or ethnicity, B) vaginal posterior fornix pH, 
C) subject age, and D) BMI. Samples’ scatter plots are shown with lines indicating best 
simple linear fit. Race/ethnicity and vaginal pH are particularly strong associations; age and 
BMI are more representative of typically modest phenotypic associations (Sup. Table 3), 
suggesting that variation in the healthy microbiota may correspond to other host or 
environmental factors.
Page 17
Nature. Author manuscript; available in PMC 2013 February 05.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
